TrialEuropean journal of heart failure2018

Sacubitril/valsartan reduces serum uric acid concentration, an independent predictor of adverse outcomes in PARADIGM-HF.

Ulrik M Mogensen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.